301111.SZ
粤万年青
SZSE · Healthcare · C 制造业 · CN
CNY 21.07
−3.04%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 310.0M | 314.6M | 278.6M | 292.4M | 283.3M |
| Cost of Revenue | 128.4M | 123.8M | 84.4M | 91.9M | 92.1M |
| Gross Profit | 181.6M | 190.9M | 194.3M | 200.5M | 191.2M |
| Operating Expenses | |||||
| R&D Expense | 8.6M | 8.5M | 8.4M | 8.4M | 9.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 48.3M | 50.5M | 51.4M | 25.9M | 18.0M |
| Selling & Marketing Expense | 138.6M | 146.5M | 137.1M | 138.4M | 137.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 200.9M | 211.2M | 201.6M | 174.7M | 166.9M |
| Cost and Expenses | 329.3M | 335.0M | 286.0M | 266.7M | 259.0M |
| Operating Income (EBIT) | (10.5M) | (10.2M) | 884.1K | 41.2M | 43.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (9.9M) | (9.8M) | (143.6K) | 37.3M | 34.8M |
| Income Tax Expense | (1.3M) | (626.8K) | (1.4M) | 4.8M | 1.3M |
| Bottom Line | |||||
| Net Income | (4.4M) | (4.5M) | 4.2M | 33.5M | 33.4M |
| Earnings from Cont. Ops | (8.6M) | (9.1M) | 1.2M | 32.5M | 33.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (4.4M) | (4.5M) | 4.2M | 33.5M | 33.4M |
| Per Share | |||||
| Basic EPS | (CN¥0.03) | (CN¥0.03) | CN¥0.03 | CN¥0.21 | CN¥0.21 |
| Diluted EPS | (CN¥0.03) | (CN¥0.03) | CN¥0.03 | CN¥0.21 | CN¥0.21 |
| Revenue Per Share | CN¥1.94 | CN¥2.10 | CN¥2.01 | CN¥1.83 | CN¥1.78 |
| Shares | |||||
| Basic Shares Outstanding | 159.7M | 149.6M | 138.8M | 159.5M | 159.1M |
| Diluted Shares Outstanding | 159.7M | 149.6M | 138.8M | 159.5M | 159.1M |
| Profitability Metrics | |||||
| EBITDA | — | 3.6M | 13.4M | 52.0M | 54.4M |
| D&A | — | 13.8M | 12.5M | 10.8M | 11.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026